Impact of size of the tumor, persistence of estrogen receptors, progesterone receptors, HER2neu receptors and Ki67 values on positivity of axillar lymph nodes at patients with early breast cancer with clinically negative axillar examination
DOI:
https://doi.org/10.3889/oamjms.2017.213Keywords:
early breast cancer, factors that predict axillar status, tumor size, lymphovascular invasion, Ki67Abstract
Aim: The aim of the study was to identify factors that influence the positivity on axillar status at patients with early breast cancer with clinical negative axilla, at which were done radical surgery to breast but also radical lymphadenectomy of axillar lymph nodes.
Material and methods: In the study were included 81 surgically treated patients with early breast cancer during 08-2015 to 05-2017 year. All the cases have been analyzed by standard histological analysis including macroscopic and microscopic analysis on standard H&E staining. For determining of molecular receptors immunostaining by PT LINK immunoperoxidase has been done for HER2neu, ER, PR, p53 and Ki67.  Â
Results: Patients age ranged between 31-73 years, average of 56.86 years. The mean size of the primary tumor in the surgically treated patient was 20.33 + 6.0 mm. On dissection from the axilary pits there were taken out 5 to 32 lymph nodes, an average of 14. Metastases have been found in 1 to 7 lymph nodes, an average 0.7. In only 26 (32.1%) of the patients have been found metastases in the axillary lymph nodes. The univariant regression analysis showed that the size of tumor and presence of HER2 neu receptors on cancer cell influence on the positivity of the axillary lymph nodes. The presence of the estrogen receptors, progesterone receptors  showed that they do not have influence on the positivity for metastatic deposits in axillary lymph nodes. Multivariant model and logistic regression analysis as independent significant factors or predictors of positivity of the axillary lymph nodes is influenced from the tumor size only.
Conclusion: Our study showed that the involving of the axillary lymph nodes is mainly influenced from the size of the tumor and presence of HER2neu receptors  in the univariant analysis points the important influence of positivity in the axillary lymph nodes but only size of the tumor in multivariate regressive analysis.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181–187. https://doi.org/10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H
Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Annals of Surgery. 1994;220(3):391–401. https://doi.org/10.1097/00000658-199409000-00015 PMid:8092905 PMCid:PMC1234400
Maunsell E, Brisson J & Deshenes L. Arm problems and psychological distress after surgery for breast cancer. Canadian Journal of Surgery 1993; 36: 315–320. PMid:8370012
Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med. 2002; 347(8):567–575. https://doi.org/10.1056/NEJMoa020128 PMid:12192016
Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancer of the breast. N Engl J Med. 1981; 305(1):6–11. https://doi.org/10.1056/NEJM198107023050102 PMid:7015141
Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Archives of Surgery. 1996; 131:301–308. https://doi.org/10.1001/archsurg.1996.01430150079015 PMid:8611096
Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 1997;79:1918–22. https://doi.org/10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO;2-Y
Tan YY, Wu CT, Fan YG, et al. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Breast J. 2005;11:338–43. https://doi.org/10.1111/j.1075-122X.2005.00043.x PMid:16174155
Ravdin PM, De Laurentiis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst. 1994;86:1771–75. https://doi.org/10.1093/jnci/86.23.1771 PMid:7966415
Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003;10:248–54. https://doi.org/10.1245/ASO.2003.05.020 PMid:12679309
Patani NR, Dwek MV, Douek M.Predictors of axillary lymph node metastasis in breast cancer: a systematic review. Eur J Surg Oncol. 2007; 33(4):409-19. https://doi.org/10.1016/j.ejso.2006.09.003 PMid:17125963
Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014;15(8):e351-62. https://doi.org/10.1016/S1470-2045(13)70590-4
Byon W, Kim E, Kwon J, Song BJ, Park C. FDG-PET, MRI and USG in the assesment of axillary lymph node metastases in breast cancer. The Breast. 2015; 24:S1-S67. https://doi.org/10.1016/S0960-9776(15)70165-7
Hwang SO, Lee SW, Kim HJ, Kim WW, Park HY, Jung JH. The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18)F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer. J Breast Cancer. 2013;16(3):315-21. https://doi.org/10.4048/jbc.2013.16.3.315 PMid:24155761 PMCid:PMC3800728
Hyun SJ, Kim EK, Yoon JH, Moon HJ, Kim MJ. Adding MRI to ultrasound and ultrasound-guided fine-needle aspiration reduces the false-negative rate of axillary lymph node metastasis diagnosis in breast cancer patients. Clin Radiol. 2015;70(7):716-22. https://doi.org/10.1016/j.crad.2015.03.004 PMid:25917544
Kondov B, Milenkovikj Z, Spirovski Z, Popgjorceva D, Stojanovski S, Petrusevska G, Ivkovski Lj, Jovanovski-Srceva M, Kondov G. Application of "sentinel lymph node detection" in axilla in patients surgically treated for early breast cancer. Physioacta. 2016; 10(2):53-62.
Kondov B, Kondov G, Spirovski Z, Milenkovikj Z, Colanceski R, Petrusevska G, Pesevska M. Prognostic factors on the positivity for metastases of the axillary lymph nodes from primary breast cancer- Pril. 2017; 37:1-10.
Giuliano AE, Han SH. Local and regional control in breast cancer: role of sentinel node biopsy. Adv Surg. 2011; 45:101-16. https://doi.org/10.1016/j.yasu.2011.03.015
Mamounas ET.Optimal Management of the Axilla: A Look at the Evidence. Adv Surg. 2016;50(1):29-40. https://doi.org/10.1016/j.yasu.2016.03.003 PMid:27520860
Moncayo VM, Aarsvold JN, Grant SF, Bartley SC, Alazraki NP. Status of sentinel lymph node for breast cancer. Semin Nucl Med. 2013;43(4):281-93. https://doi.org/10.1053/j.semnuclmed.2013.02.004 PMid:23725990
Gherghe M, Bordea C, Blidaru A. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life. 2015;8(2):176-80. PMid:25866575 PMCid:PMC4392088
Zervoudis S, Iatrakis G, Tomara E, Bothou A, Papadopoulos G, Tsakiris G.Main controversies in breast cancer. World J Clin Oncol. 2014;5(3):359-73. https://doi.org/10.5306/wjco.v5.i3.359 PMid:25114851 PMCid:PMC4127607
Postacı H, Zengel B, Yararbaş U, Uslu A, Eliyatkın N, Akpınar G, Cengiz F, Durusoy R. Sentinel lymph node biopsy in breast cancer: predictors of axillary and non-sentinel lymph node involvement. Balkan Med J. 2013;30(4):415-21. https://doi.org/10.5152/balkanmedj.2013.9591 PMid:25207151 PMCid:PMC4115951
Jiao D, Qiao J, Lu Z, Li L, Zhang H, Liu H, Cui S, Liu Z. [Analysis of predictive factors affecting sentinel lymph node status in early breast cancer patients]. Zhonghua Zhong Liu Za Zhi. 2014;36(3):198-201. PMid:24785280
Jans BJ, Escudero MN, Pulgar BD, Acevedo CF, Sánchez RC, Camus AM. Clinicopathologic subtypes and compromise of lymph nodes in patients with breast cancer. eCancer Medical Science. 2014;8.
Ugras S, Stempel M, Patil S, Morrow M. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement. Ann Surg Oncol. 2014;21(12):3780-6. https://doi.org/10.1245/s10434-014-3851-y PMid:24952028 PMCid:PMC4362539
Gangi A, Mirocha J, Leong T, Giuliano AE. Triple-negative breast cancer is not associated with increased likelihood of nodal metastases. Ann Surg Oncol. 2014;21(13):4098-103. https://doi.org/10.1245/s10434-014-3989-7 PMid:25155393
Pijnappel EN, Bhoo-Pathy N, Suniza J, See MH, Tan GH, Yip CH, Hartman M, Taib NA, Verkooijen HM. Prediction of lymph node involvement in patients with breast tumors measuring 3-5 cm in a middle-income setting: the role of Cancer Math. World J Surg. 2014;38(12):3133-7. https://doi.org/10.1007/s00268-014-2752-3 PMid:25167896
Sawaki M, Idota A, Ichikawa M, Gondo N, Horio A, Kondo N, Hattori M, Fujita T, Yatabe Y, Iwata H. Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer. Oncol Lett. 2014;8(4):1707-1712. https://doi.org/10.3892/ol.2014.2333
Brenin DR, Manasseh DM, El-Tamer M, Troxel A, Schnabel F, Ditkoff BA, Kinne D. Factors correlating with lymph node metastases in patients with T1 breast cancer. Ann Surg Oncol. 2001; 8(5):432-7. https://doi.org/10.1007/s10434-001-0432-7 PMid:11407518
Chung MJ, Lee JH, Kim SH, Suh YJ, Choi HJ.Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer. Medicine (Baltimore). 2016;95(20):e3689. https://doi.org/10.1097/MD.0000000000003689 PMid:27196477 PMCid:PMC4902419
Chadha M, Chabon AB, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis. Cancer. 1994;73(2):350-3. https://doi.org/10.1002/1097-0142(19940115)73:2<350::AID-CNCR2820730219>3.0.CO;2-5
Tan LG, Tan YY, Heng D, Chan MY. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore. Singapore Med J. 2005;46(12):693-7. PMid:16308642
Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg. 1999;230(5):692-6. https://doi.org/10.1097/00000658-199911000-00012 PMid:10561094 PMCid:PMC1420924
Qiu PF, Liu JJ, Wang YS, Yang GR, Liu YB, Sun X, Wang CJ, Zhang ZP. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram inbreast cancer patients. Jpn J Clin Oncol. 2012;42(11):1002-7. https://doi.org/10.1093/jjco/hys150 PMid:23100610
Ashturkar AV, Pathak GS, Deshmukh SD, Pandave HT. Factors predicting the axillary lymph node metastasis in breast cancer: is axillary node clearance indicated in every breast cancer patient?: factors predicting the axillary lymphnode metastases in breast cancer. Indian J Surg. 2011;73(5):331-5. https://doi.org/10.1007/s12262-011-0315-5 PMid:23024536 PMCid:PMC3208716
Wu SG, He ZY, Ren HY, Yang LC, Sun JY, Li FY, Guo L, Lin HX. Use of CEA and CA15-3 to Predict Axillary Lymph Node Metastasis in Patients with Breast Cancer. J Cancer. 2016;7(1):37-41. https://doi.org/10.7150/jca.13090 PMid:26722358 PMCid:PMC4679379
Tseng HS, Chen LS, Kuo SJ, Chen ST, Wang YF, Chen DR. Tumor characteristics of breast cancer in predicting axillary lymph node metastasis. Med Sci Monit. 2014;20:1155-61. https://doi.org/10.12659/MSM.890491 PMid:24998473 PMCid:PMC4099209
Ko BS, Lim WS, Kim HJ, Yu JH, Lee JW, Kwan SB, Lee YM, Son BH, Gong GY, Ahn SH. Risk factor for axillary lymph node metastases in microinvasive breast cancer. Ann Surg Oncol. 2012;19(1):212-6. https://doi.org/10.1245/s10434-011-1812-2 PMid:21633867
Ngô C, Mouttet D, De Rycke Y, Reyal F, Fourchotte V, Hugonnet F, Falcou MC, Bidard FC, Vincent-Salomon A, Fourquet A, Alran S. Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma. Eur J Surg Oncol. 2012;38(12):1211-7. https://doi.org/10.1016/j.ejso.2012.08.007 PMid:22954526
Yoo SH, Park IA, Chung YR, Kim H, Lee K, Noh DY, Im SA, Han W, Moon HG, Lee KH, Ryu HS. A histomorphologic predictive model for axillary lymph node metastasis in preoperative breastcancer core needle biopsy according to intrinsic subtypes. Hum Pathol. 2015; 46(2):246-54. https://doi.org/10.1016/j.humpath.2014.10.017 PMid:25496835
Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA Jr. Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up. J Am Coll Surg. 2010;210(5):797-805.e1. https://doi.org/10.1016/j.jamcollsurg.2010.02.045 PMid:20421053
Cabioglu N, Yazici MS, Arun B, Broglio KR, Hortobagyi GN, Price JE, Sahin A. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res. 2005;11(16):5686-93. https://doi.org/10.1158/1078-0432.CCR-05-0014 PMid:16115904
Capdet J, Martel P, Charitansky H, Lim YK, Ferron G, Battle L, Landier A, Mery E, Zerdoub S, Roche H, Querleu D - Factors predicting the sentinel node metastases in T1 breast cancer tumor: an analysis of 1416 cases. Eur J Surg Oncol. 2009; 35(12):1245-9. https://doi.org/10.1016/j.ejso.2009.06.002 PMid:19574018
Susini T, Nori J, Olivieri S, Molino C, Marini G, Bianchi S, Vezzosi V, Livi L, Mascalchi M, Scarselli G. Predicting the status of axillary lymph nodes in breast cancer: a multiparameter approach including axillary ultrasound scanning. Breast. 2009;18(2):103-8. https://doi.org/10.1016/j.breast.2009.02.001 PMid:19285396
Wasuthit Y, Kongdan Y, Suvikapakornkul R, Lertsithichai P, Chirappapha P. Predictive factors of axillary lymph node metastasis in breast cancer. J Med Assoc Thai. 2011;94(1):65-70. PMid:21425730
Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426-32. https://doi.org/10.1097/SLA.0b013e3181f08f32
Meattini I, Saieva C, Bertocci S, Francolini G, Zei G, De Luca Cardillo C, Scotti V, Greto D, Bonomo P, Orzalesi L, Bianchi S, Livi L. Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node. Tumori. 2015; 101(1):78-83. https://doi.org/10.5301/tj.5000220 PMid:25702658
Nadeem RM, Gudur LD, Saidan ZA. An independent assessment of the 7 nomograms for predicting the probability of additional axillary nodal metastases after positive sentinel lymph node biopsy in a cohort of British patients with breastcancer. Clin Breast Cancer. 2014;14(4):272-9. https://doi.org/10.1016/j.clbc.2014.02.006 PMid:25037530
van den Hoven I, Kuijt G, Roumen R, Voogd A, Steyerberg EW, Vergouwe Y. A head to head comparison of nine tools predicting non-sentinel lymph node status in sentinel node positive breast cancer women.J Surg Oncol. 2015;112(2):133-8. https://doi.org/10.1002/jso.23992 PMid:26258749
van den Hoven I, van Klaveren D, Voogd AC, Vergouwe Y, Tjan-Heijnen V, Roumen RM. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients. Clin Breast Cancer. 2016;16(2):123-30. https://doi.org/10.1016/j.clbc.2015.09.003 PMid:26602438
Kuo YL, Chen WC, Yao WJ, Cheng L, Hsu HP, Lai HW, Kuo SJ, Chen DR, Chang TW. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison. Int J Surg. 2013;11(7):538-43. https://doi.org/10.1016/j.ijsu.2013.05.005 PMid:23707626
Cordero JM, Bernet L, Cano R, Bustamante M, Vila R, Ballester B, González PJ. [Study of the sentinel node in breast cancer using lymphoscintigraphy and a fast method for cytokeratin]. Rev Esp Med Nucl. 2004;23(1):9-14. https://doi.org/10.1016/S0212-6982(04)72239-9
Gur AS, Unal B, Johnson R, Ahrendt G, Bonaventura M, Gordon P, Soran A. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.J Am Coll Surg. 2009;208(2):229-35. https://doi.org/10.1016/j.jamcollsurg.2008.10.029 PMid:19228534
Gur AS, Unal B, Ozbek U, Ozmen V, Aydogan F, Gokgoz S, Gulluoglu BM, Aksaz E, Ozbas S, Baskan S, Koyuncu A, Soran A; Turkish Federation of Breast Disease Associations Protocol MF08-01 investigators. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol. 2010;36(1):30-5. https://doi.org/10.1016/j.ejso.2009.05.007 PMid:19535217
Cserni G, Bori R, Maráz R, Leidenius MH, Meretoja TJ, Heikkila PS, Regitnig P, Luschin-Ebengreuth G, Zgajnar J, Perhavec A, Gazic B, Lázár G, Takács T, Vörös A, Audisio RA. Multi-institutional comparison of non-sentinel lymph node predictive tools in breast cancer patients with high predicted risk of further axillary metastasis. Pathol Oncol Res. 2013;19(1):95-101. https://doi.org/10.1007/s12253-012-9553-5 PMid:22798061
Cserni G, Boross G, Maráz R, Leidenius MH, Meretoja TJ, Heikkila PS, Regitnig P, Luschin-Ebengreuth G, Zgajnar J, Perhavec A, Gazic B, Lázár G, Takács T, Vörös A, Audisio RA. Multicentre validation of different predictive tools of non-sentinel lymph node involvement in breast cancer. Surg Oncol. 2012;21(2):59-65. https://doi.org/10.1016/j.suronc.2011.12.001 PMid:22197294
Freedman GM, Fowble BL, Li T, Hwang ES, Schechter N, Devarajan K, Anderson PR, Sigurdson ER, Goldstein LJ, Bleicher RJ. Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status. Breast J. 2014;20(4):358-63. https://doi.org/10.1111/tbj.12276 PMid:24861613 PMCid:PMC4472437
Gülben K, Berberoğlu U, Aydoğan O, Kınaş V. Subtype is a predictive factor of nonsentinel lymph node involvement in sentinel node-positive breast cancer patients. J Breast Cancer. 2014;17(4):370-5. https://doi.org/10.4048/jbc.2014.17.4.370 PMid:25548586 PMCid:PMC4278057
Williams C, Lin C-Y. Oestrogen receptors in breast cancer: basic mechanisms and clinical implications; Ecancer Medical Science. 2013; 7: 370. PMid:24222786 PMCid:PMC3816846
Gutierrez C, Schiff R. HER 2: Biology, Detection, and Clinical Implications. Arch Pathol Lab Med. 2011; 135(1): 55–62. PMid:21204711 PMCid:PMC3242418
van Diest PJ, van der Wall E, Baak JPA. Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol. 2004; 57(7): 675–681. https://doi.org/10.1136/jcp.2003.010777 PMid:15220356 PMCid:PMC1770351
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
